Results 121 to 130 of about 44,840 (262)

Inflammatory Bowel Disease Outcomes in Northern Iran: A Retrospective Cohort Study of Remission, Complications, and Treatment Strategies

BioMed Research International, Volume 2026, Issue 1, 2026.
Background Inflammatory bowel disease (IBD), encompassing Crohn′s disease (CD) and ulcerative colitis (UC), is a chronic inflammatory condition affecting the gastrointestinal tract. While significant progress has been made in managing IBD, the long‐term outcomes remain heterogeneous, prompting this cohort study.
Poria Hoseinialiabadi, Iradj Maleki, Hafez Fakheri, Mahboobe Ebrahimi, Elham Yousefi Abdolmaleki, Tarang Taghvaei, Hajar Shokri-Afra, Baisakhi Banerjee   +7 more
wiley   +1 more source

<i>Clostridioides difficile</i> infection during the COVID-19 pandemic: a gut microbiota–based relationship [PDF]

, 2021
Giovanni Cammarota, Federica Giambò, Gianluca Ianiro   +2 more
openalex   +1 more source

One Swallow Does Not Make a Summer: A Confirmed Case of Imported Vibrio cholerae After Clostridioides difficile Diagnosis in Brescia, Northern Italy

Case Reports in Infectious Diseases, Volume 2026, Issue 1, 2026.
Vibrio cholerae, the aetiological agent of cholera, is predominantly an imported pathogen in high‐income countries. We report a case of a 49‐year‐old Nigerian male returning from Africa with abdominal pain and watery diarrhea, who rapidly developed acute kidney injury.
Cristina Seguiti, Elia Croce, Enza Granato, Alessia Giovannini, Stefano Grossi, Marcello Cecere, Daniela Fortini, Laura Villa, Anna Caruana, Gabriele Del Castillo, Luigi Vezzosi, Danilo Cereda, Angelo Meloni, Paolo Colombini, Priya Gusain   +14 more
wiley   +1 more source

European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.

Clinical Microbiology and Infection, 2021
J. van Prehn, E. Reigadas, E. Vogelzang, E. Bouza, A. Hristea, B. Guery, M. Krutova, T. Norén, F. Allerberger, J. Coia, A. Goorhuis, T. V. van Rossen, R. Ooijevaar, K. Burns, B. R. Scharvik Olesen, S. Tschudin-Sutter, M. Wilcox, M. Vehreschild, F. Fitzpatrick, E. Kuijper   +19 more
semanticscholar   +1 more source

Influence of Antibiotic Exposure Intensity on the Risk of Clostridioides difficile Infection.

Clinical Infectious Diseases
BACKGROUND Antibiotics are a strong risk factor for Clostridioides difficile infection (CDI), and CDI incidence is often measured as an important outcome metric for antimicrobial stewardship interventions aiming to reduce antibiotic use. However, risk of
Michael J. Ray, Luke C. Strnad, Kendall J. Tucker, Jon P. Furuno, Eric Lofgren, Caitlin M. McCracken, Hiro Park, Jeffrey S. Gerber, Jessina C. McGregor   +8 more
semanticscholar   +1 more source

Pathophysiological Mechanisms and Nonpharmacological Interventions in Irritable Bowel Syndrome: Current Insights and Future Directions

Journal of Nutrition and Metabolism, Volume 2026, Issue 1, 2026.
Irritable bowel syndrome, diagnosed using the ROME IV diagnostic criteria, is one of the most common dysfunctional disorders of the gastrointestinal system with a high global prevalence. Although symptom presentation is diverse, symptoms primarily manifest as abdominal pain, bloating, and alterations to bowel habits, negatively impacting quality of ...
Stefanie L. Y. Cheung, Leanne C. Kenway, Maharshi Bhaswant   +2 more
wiley   +1 more source

1186. Decreased Laboratory-Identified Clostridioides difficile Infections with Implementation of an Electronic Hand Hygiene Monitoring System in a Long-Term Acute Care Hospital Decreased Laboratory-Identified Clostridioides difficile Infections with Implementation of an Electronic Hand Hygiene Monitoring System in a Long-Term Acute Care Hospital [PDF]

, 2019
Maureen Banks, Andrew Phillips, Keith C. Chin, Lou Ann Bruno‐Murtha   +3 more
openalex   +1 more source

Colocutaneous fistula following Clostridioides difficile infection managed as an ‘autocolostomy’: a novel approach to a recognised complication

, 2021
Marriam Ahmed, Kiran Randhawa, Anthony Kawesha, Akinfemi Akingboye   +3 more
openalex   +2 more sources

1985. Impact of Suppressing Ciprofloxacin Susceptibility Results on Antibiotic Utilization and Hospital-acquired Clostridioides difficile Infection [PDF]

, 2019
Bryan P. White, Daniel B. Chastain, Karen K. Kinney, Katie Thompson, Jerry Kelley, Cindy B. McCloskey   +5 more
openalex   +1 more source

Laboratory diagnostic methods for clostridioides difficile infection

One Health & Risk Management, 2023
Introduction. Clostridioides difficile is an anaerobic gram-positive, sporeforming, toxin-producing bacillus that is transmitted among humans through the fecal-oral route, as a result of ingestion of spores. Colonization of C.
Anastasia ALEXANDROV
doaj